Schedule 13G ownership disclosure

CERO THERAPEUTICS HOLDINGS, INC.

Common Stock · CUSIP: 15687V102

Event date: 2026-02-19

Filing-level shares
1,830,007
Percent of class
8.67%
  • Tibbs Isaiah

    Shares: 1,830,007 · Class: 8.67%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001376474-26-000232
Form type
SCHEDULE 13G
Filer
CERO THERAPEUTICS HOLDINGS, INC.
CIK
CIK 1870404
Filed
Mar 12, 2026
Reporting period
Feb 19, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub